Lessee, Operating Lease, Liability, to be Paid of REGENERON PHARMACEUTICALS, INC. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
REGENERON PHARMACEUTICALS, INC. quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • REGENERON PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 31 Dec 2025 was $321,900,000, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

REGENERON PHARMACEUTICALS, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $321,900,000 +$31,000,000 +11% 31 Dec 2025 10-K 04 Feb 2026 2025 FY
Q4 2024 $290,900,000 +$187,600,000 +182% 31 Dec 2024 10-K 05 Feb 2025 2024 FY
Q4 2023 $103,300,000 31 Dec 2023 10-K 05 Feb 2024 2023 FY
Q4 2019 $26,100,000 31 Dec 2019 10-K 07 Feb 2020 2019 FY
Q3 2019 $28,400,000 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $30,700,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $32,500,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.